| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |